These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 19207128)

  • 1. Risperidone long-acting injection: a 6-year mirror-image study of healthcare resource use.
    Taylor D; Fischetti C; Sparshatt A; Thomas A; Bishara D; Cornelius V
    Acta Psychiatr Scand; 2009 Aug; 120(2):97-101. PubMed ID: 19207128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health resource utilization associated with switching to risperidone long-acting injection.
    Young CL; Taylor DM
    Acta Psychiatr Scand; 2006 Jul; 114(1):14-20. PubMed ID: 16774656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risperidone long-acting injection: factors associated with changes in bed stay and hospitalisation in a 3-year naturalistic follow-up.
    Taylor D; Cornelius V
    J Psychopharmacol; 2010 Jul; 24(7):995-9. PubMed ID: 19282424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.
    Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J
    Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment retention with risperidone long-acting injection: 24-month results from the Electronic Schizophrenia Treatment Adherence Registry (e-STAR) in six countries.
    Peuskens J; Olivares JM; Pecenak J; Tuma I; Bij de Weg H; Eriksson L; Resseler S; Akhras K; Jacobs A
    Curr Med Res Opin; 2010 Mar; 26(3):501-9. PubMed ID: 20014981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of risperidone long acting injection on resource utilization in psychiatric secondary care.
    Taylor M; Currie A; Lloyd K; Price M; Peperell K
    J Psychopharmacol; 2008 Mar; 22(2):128-31. PubMed ID: 18308820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risperidone long-acting injection: a prospective 3-year analysis of its use in clinical practice.
    Taylor DM; Fischetti C; Sparshatt A; Thomas A; Bishara D; Cornelius V
    J Clin Psychiatry; 2009 Feb; 70(2):196-200. PubMed ID: 19026261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Healthcare resource utilization during 1-year treatment with long-acting, injectable risperidone.
    Leal A; Rosillon D; Mehnert A; Jarema M; Remington G
    Pharmacoepidemiol Drug Saf; 2004 Nov; 13(11):811-6. PubMed ID: 15386706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Explicit review of risperidone long-acting injection prescribing practice.
    Wheeler A; Vanderpyl J; Carswell C; Stojkovic M; Robinson E
    J Clin Pharm Ther; 2011 Dec; 36(6):651-63. PubMed ID: 22023342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective, open study of long-acting injected risperidone versus oral antipsychotics in 88 chronically psychotic patients.
    Girardi P; Serafini G; Pompili M; Innamorati M; Tatarelli R; Baldessarini RJ
    Pharmacopsychiatry; 2010 Mar; 43(2):66-72. PubMed ID: 20099224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. One-year treatment continuation in patients prescribed risperidone long-acting injection in New Zealand: a retrospective study.
    Wheeler A; Vanderpyl J; Carswell C; Stojkovic M; Robinson E
    Clin Schizophr Relat Psychoses; 2012 Jul; 6(2):61-8. PubMed ID: 22776632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thirty-five months experience of risperidone long-acting injection in a UK psychiatric service including a mirror-image analysis of in-patient care.
    Niaz OS; Haddad PM
    Acta Psychiatr Scand; 2007 Jul; 116(1):36-46. PubMed ID: 17559599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and resource-use outcomes of risperidone long-acting injection in recent and long-term diagnosed schizophrenia patients: results from a multinational electronic registry.
    Olivares JM; Peuskens J; Pecenak J; Resseler S; Jacobs A; Akhras KS;
    Curr Med Res Opin; 2009 Sep; 25(9):2197-206. PubMed ID: 19604073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term safety and efficacy of long-acting risperidone in elderly psychotic patients.
    Kissling W; Glue P; Medori R; Simpson S
    Hum Psychopharmacol; 2007 Dec; 22(8):505-13. PubMed ID: 17902187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of health services use following the initiation of risperidone long-acting therapy among schizophrenia patients in the veterans health administration.
    Ren XS; Crivera C; Sikirica M; Dirani R; Qian S; Kazis LE
    J Clin Pharm Ther; 2011 Jun; 36(3):383-9. PubMed ID: 21062329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Long-acting injectable risperidone: naturalistic study in three hospitals in Aquitaine].
    Raignoux C; Dusouchet T; Bret P; Queuille E; Biscay ML; Caron J; Bret MC
    Encephale; 2007 Dec; 33(6):973-81. PubMed ID: 18789790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A cost-consequence analysis of long-acting injectable risperidone in schizophrenia: a one-year mirror-image study with national claim-based database in Taiwan.
    Chang HC; Tang CH; Huang ST; McCrone P; Su KP
    J Psychiatr Res; 2012 Jun; 46(6):751-6. PubMed ID: 22440883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Remission in schizophrenia: one-year Italian prospective study of risperidone long-acting injectable (RLAI) in patients with schizophrenia or schizoaffective disorder.
    Rossi A; Bagalà A; Del Curatolo V; Scapati F; Bernareggi MM; Giustra MG;
    Hum Psychopharmacol; 2009 Oct; 24(7):574-83. PubMed ID: 19790173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A controlled, mirror-image study of second-generation antipsychotics in the treatment of schizophrenia.
    Taylor D; Hayhurst K; Kerwin R
    Int Clin Psychopharmacol; 2007 May; 22(3):133-6. PubMed ID: 17414738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relapse and long-acting injectable risperidone: a 1-year mirror image study with a national claims database in Taiwan.
    Su KP; Chang HC; Tsai SJ; Yen FC; Tang CH
    Value Health; 2009; 12 Suppl 3():S118-21. PubMed ID: 20586973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.